Literature DB >> 22293615

Metabolism: Keeping fit with autophagy.

Rachel David.   

Abstract

Year:  2012        PMID： 22293615     DOI： 10.1038/nrm3287

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN： 1471-0072            Impact factor:   94.444


× No keyword cloud information.
  1 in total

1.  Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis.

Authors:  Congcong He; Michael C Bassik; Viviana Moresi; Kai Sun; Yongjie Wei; Zhongju Zou; Zhenyi An; Joy Loh; Jill Fisher; Qihua Sun; Stanley Korsmeyer; Milton Packer; Herman I May; Joseph A Hill; Herbert W Virgin; Christopher Gilpin; Guanghua Xiao; Rhonda Bassel-Duby; Philipp E Scherer; Beth Levine
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962
  1 in total
  5 in total

1.  Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathways.

Authors:  Xiaofeng Dong; Rui Li; Peng Xiu; Xuesong Dong; Zongzhen Xu; Bo Zhai; Feng Liu; Hongchi Jiang; Xueying Sun; Jie Li; Haiquan Qiao
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

2.  MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.

Authors:  Changjun He; Xuesong Dong; Bo Zhai; Xian Jiang; Deli Dong; Baoxin Li; Hongchi Jiang; Shidong Xu; Xueying Sun
Journal:  Oncotarget       Date:  2015-10-06

3.  Prediction of Overall Survival Rate in Patients With Hepatocellular Carcinoma Using an Integrated Model Based on Autophagy Gene Marker.

Authors:  Shuaiqun Wang; Dalu Yang; Wei Kong
Journal:  Front Genet       Date:  2021-04-01       Impact factor: 4.599

4.  Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells.

Authors:  W-T Tai; C-W Shiau; H-L Chen; C-Y Liu; C-S Lin; A-L Cheng; P-J Chen; K-F Chen
Journal:  Cell Death Dis       Date:  2013-02-07       Impact factor: 8.469

5.  An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells.

Authors:  Shuyao Tang; Gang Tan; Xian Jiang; Peng Han; Bo Zhai; Xuesong Dong; Haiquan Qiao; Hongchi Jiang; Xueying Sun
Journal:  Oncotarget       Date:  2016-11-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.